New hope for teens: schizophrenia drug safety trial completed
NCT ID NCT02411695
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested the safety and how the body processes the drug brexpiprazole in 43 teenagers aged 13-17 with schizophrenia. Researchers monitored side effects and changes in vital signs over 17 days. The goal was to find a safe dose for future studies, not to measure how well it treats symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Study site
Culver City, California, 90230, United States
-
Study site
Orange, California, 92858, United States
-
Study site
Washington D.C., District of Columbia, 20016, United States
-
Study site
Atlanta, Georgia, 30331, United States
-
Study site
Marlton, New Jersey, 08053, United States
-
Study site
Cincinnati, Ohio, 45219, United States
-
Study site
Cleveland, Ohio, 44106, United States
-
Study site
The Woodlands, Texas, 77381, United States
-
Study site
Orem, Utah, 84058, United States
-
Study site
Little Rock, Arkansas, 72211, United States